Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201205130 Principal Investigator: Tabchy, Adel
Title: A Two-Cohort, Open-label, Multicenter Phase II Trial Assessing the Efficacy and Safety of Pertuzumab given in Combination with Trastuzumab and Vinorelbine in First Line Patients with HER2-positive Advanced (metastatic or locally advanced) Breast Cancer
Phase: II Disease Site: Breast, Female
Participating Site(s):
 
Main Campus
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to compare the overall response rates of pertuzumab given in combination with trastuzumab in a single infusion bag followed by vinorelbine, versus giving pertuzumab, trastuzumab and vinorelbine given in separate infusion bags. The results of this study could minimize in-clinic time and therefore make treatments more convenient for patients.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)